BMS Says Genetic Technologies' DNA Tech Is Unpatentable

Law360, Los Angeles (February 4, 2014, 6:00 PM EST) -- Bristol-Myers Squibb Co. on Tuesday urged a Delaware federal court to dismiss Australian company Genetic Technologies Ltd.'s suit accusing it of infringing patents relating to DNA technology, arguing the patents cover an unpatentable law of nature.

BMS contends that Genetic Technologies' U.S. Patent Numbers 5,612,179 and 5,851,762, which are directed to technology for identifying genetic variations, merely recite the use of widely known processes to observe a naturally occurring phenomenon.

"The patents asserted by [Genetic Technologies] against BMS do no more than recite a law of...
To view the full article, register now.